About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Acute Cognition and Exercise | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT05078203

Acute Cognition and Exercise

The central hypothesis is that, while both groups will benefit from the exercise session, participants with obesity will exhibit greater gains in cognitive control, relative to healthy weight adults. ...

Lead sponsor: University of Illinois at Urbana-Champaign•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

University of Illinois at Urbana-Champaign

18 adults with healthy weight (BMI 18.5-25.0kg/m2) and 18 adults with obesity (BMI 30.0kg/m2) will be asked to complete a counter-balanced crossover trial. After initial baseline testing, participants will be asked to complete either an acute exercise bout or sedentary control session in a counter-balanced order. A cognitive testing battery accompanied by an electroencephalogram (EEG) will be administered following each session. Blood samples will be collected prior to, during, and following each throughout each testing condition.

Age

18 - 35 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Between ages 18 and 35
•No prior diagnosis of neurological disorders (e.g., autism spectrum disorder)
•No prior diagnosis of metabolic disease (e.g., diabetes, cardiovascular disease)
•No physical disability that would preclude the participant from completing a VO2max test
•Corrected vision (based on the minimal 20/20 standard needed to complete cognitive tasks)
•Not pregnant
•BMI between 18.5 and 25.0 kg/m2, or BMI greater than 30.0 kg/m2
•Readiness for exercise (determined through PAR-Q)

Exclusion Criteria

•\<18 years and \>35 years
•Diagnosis of neurological disorders (e.g., autism spectrum disorder)
•Diagnosis of metabolic disease (e.g., diabetes, cardiovascular disease)
•Physical disability that would preclude the participant from completing a VO2max test
•Lack of corrected vision (based on the minimal 20/20 standard needed to complete cognitive tasks)
•Pregnancy
•BMI less than 18.5 kg/m2 or BMI greater than 25.0 but less than 30.0 kg/m2

Related studies

RECRUITINGPhase 3

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

NCT07351045 · Obesity or Overweight

The ISAR InflEx Trial (Inflammation and Exercise)

NCT07543666 · Inflammation, Obesity (Disorder)

RECRUITINGPhase 3

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

NCT07037459 · Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, and more

Dietary Peanuts and Nutrition-Related Outcomes

NCT07244458 · Dietary Change, Obesity & Overweight, and more

RECRUITINGPhase 1

A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity

NCT07508241 · Obesity, Overweight and/or Obesity, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 20, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment26

Start dateSep 2021

Last updatedFeb 20, 2024

Condition

Locations shown

University of Illinois at Urbana-Champaign

Urbana, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 20, 2024Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions